Lantern Pharma Inc (LTRN)
5.44
+0.11
(+2.06%)
USD |
NASDAQ |
May 02, 09:57
Lantern Pharma Net Income (Quarterly): -4.186M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -4.186M |
September 30, 2023 | -3.161M |
June 30, 2023 | -4.746M |
March 31, 2023 | -3.868M |
December 31, 2022 | -3.381M |
September 30, 2022 | -2.265M |
June 30, 2022 | -4.492M |
March 31, 2022 | -4.122M |
December 31, 2021 | -3.540M |
September 30, 2021 | -4.054M |
Date | Value |
---|---|
June 30, 2021 | -2.316M |
March 31, 2021 | -2.452M |
December 31, 2020 | -2.896M |
September 30, 2020 | -1.702M |
June 30, 2020 | -0.8334M |
March 31, 2020 | -0.4773M |
December 31, 2019 | -0.6752M |
September 30, 2019 | -0.6697M |
June 30, 2019 | -0.6294M |
March 31, 2019 | -0.454M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-4.746M
Minimum
Jun 2023
-0.4773M
Maximum
Mar 2020
-2.656M
Average
-2.896M
Median
Dec 2020
Net Income (Quarterly) Benchmarks
Eyenovia Inc | -7.967M |
Cassava Sciences Inc | -20.92M |
Alpine Immune Sciences Inc | 5.96M |
Clearside Biomedical Inc | -4.832M |
Poseida Therapeutics Inc | -25.35M |
Net Income (Quarterly) Related Metrics
Total Expenses (Quarterly) | 4.877M |
EPS Diluted (Quarterly) | -0.39 |
Enterprise Value | 15.95M |
Earnings Yield | -27.21% |